title: Candida albicans isolates from APECED patients show decreased susceptibility to miconazole.
authors.forename: Emilia
authors.initials: E
authors.lastname: Siikala
authors.forename: Malcolm
authors.initials: M
authors.lastname: Richardson
authors.forename: Michael A
authors.initials: MA
authors.lastname: Pfaller
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Diekema
authors.forename: Shawn A
authors.initials: SA
authors.lastname: Messer
authors.forename: Jaakko
authors.initials: J
authors.lastname: Perheentupa
authors.forename: Harri
authors.initials: H
authors.lastname: Saxén
authors.forename: Riina
authors.initials: R
authors.lastname: Rautemaa
mesh_terms: D000935:Antifungal Agents / Q000494:pharmacology*; D002176:Candida albicans / Q000187:drug effects* / Q000302:isolation & purification*; D002177:Candidiasis / Q000382:microbiology*; D006801:Humans; D008825:Miconazole / Q000494:pharmacology*; D008826:Microbial Sensitivity Tests; D016884:Polyendocrinopathies, Autoimmune / Q000150:complications*; D012871:Skin Diseases / Q000150:complications*
chemical_list: D000935:Antifungal Agents; D008825:Miconazole